MEET OUR TEAM

FOUNDERS

JOSHUA ABRAM

FOUNDER & CO-CEO

JOSHUA ABRAM

FOUNDER & CO-CEO

Prior to founding TMRW, Coriolis Ventures partners Joshua Abram and Alan Murray seed funded and served as co-CEOs of several companies at the intersection of data, machine learning, and marketing. Today, these companies employ approximately 1,200 people and routinely process tens of billions of data events every 24 hours. 

While building these technology companies, Joshua and Alan also made a significant commitment to founding and/or providing the earliest seed funding to firms that spoke to their shared interest in hospitality — specifically the creation of innovative and scaleable luxury experiences. They co-founded the paradigm-shifting NeueHouse, which brought the amenities and sensibility of a boutique hotel to the office environment. NeueHouse was widely celebrated for, as Departure Magazine wrote, fundamentally changing “what one might aspire to in a utopian, perfected office.” Joshua and Alan also seed funded Alice, a hospitality tech company that automates the guest experience at leading hotels.

Recent transactions involving firms founded or seed funded by Joshua and Alan:

• In August 2017, Expedia injected its second round of funding into Alice, bringing its total investment to $35 million.

• In January 2018, Ranger Capital, the family office of Barry Diller and Diane von Furstenberg purchased a controlling interest in NeueHouse.

• In July 2018, private equity firm Vista bought Integral Ad Science (IAS), a martech company co-founded by Joshua and Alan in 2007, in an all cash transaction totaling $850 million dollars. 

• In June 2018, AppNexus, a martech company that Joshua and Alan seed funded in 2006, was acquired by AT&T for $1.6 billion.

ALAN MURRAY

FOUNDER & CO-CEO

ALAN MURRAY

FOUNDER & CO-CEO

Prior to founding TMRW, Coriolis Ventures partners Joshua Abram and Alan Murray seed funded and served as co-CEOs of several companies at the intersection of data, machine learning, and marketing. Today, these companies employ approximately 1,200 people and routinely process tens of billions of data events every 24 hours.

While building these technology companies, Joshua and Alan also made a significant commitment to founding and/or providing the earliest seed funding to firms that spoke to their shared interest in hospitality — specifically the creation of innovative and scaleable luxury experiences. They co-founded the paradigm-shifting NeueHouse, which brought the amenities and sensibility of a boutique hotel to the office environment. NeueHouse was widely celebrated for, as Departure Magazine wrote, fundamentally changing “what one might aspire to in a utopian, perfected office.” Joshua and Alan also seed funded Alice, a hospitality tech company that automates the guest experience at leading hotels.

Recent transactions involving firms founded or seed funded by Joshua and Alan:

• In August 2017, Expedia injected its second round of funding into Alice, bringing its total investment to $35 million.

• In January 2018, Ranger Capital, the family office of Barry Diller and Diane von Furstenberg purchased a controlling interest in NeueHouse.

• In July 2018, private equity firm Vista bought Integral Ad Science (IAS), a martech company co-founded by Joshua and Alan in 2007, in an all cash transaction totaling $850 million dollars. 

• In June 2018, AppNexus, a martech company that Joshua and Alan seed funded in 2006, was acquired by AT&T for $1.6 billion.

JEFFREY PORT, MD

Founder & Chief Medical Officer 

JEFFREY PORT, MD

FOUNDER & CHIEF MEDICAL OFFICER

While practicing thoracic surgery and teaching at Weill Cornell Medical Center, Jeffrey founded and chaired two companies:

• RF Surgical Systems, which is focused on the detection and prevention of retained surgical items (sponge, gauze, or towel) during surgery, was purchased by Medtronic in 2015 for $235 million.

• Angiocrine Bioscience, which creates cellular therapies designed to drive stem cell renewal in a variety of diseases. 

Jeffrey earned his medical degree and finished his general surgery residency at New York University School of Medicine before completing surgical training at Weill Cornell and Memorial Sloan Kettering Cancer Center. He has published extensively on both immunotherapy treatment for lung and esophageal cancer and vaccine development.

OPERATING TEAM

LORI BATTA

CHIEF COMMERCIAL OFFICER

LORI BATTA

CHIEF COMMERCIAL OFFICER

Lori has over 25 years of experience in the life sciences industry, leading sales, operations, multichannel product distribution, business development, and marketing for both startup and growth organizations.

Prior to joining TMRW, Lori was Chief Commercial Officer at women’s health company Celmatix, where she oversaw the sales and customer support functions and led commercial strategy for both the Fertilome genetic test and the Polaris predictive analytics platforms.

Prior to Celmatix, Lori spent five years with genetic testing company Good Start Genetics as its Senior Vice President, Business Development and Strategic Alliances. She oversaw the launch of the first next-generation sequencing carrier screen and embryo testing and drove more than $100M in revenue in Good Start’s first three years in the market prior to the firm’s acquisition by Invitae (NASDAQ: NVTA). Before joining Good Start, she held senior roles at EMD Serono and Novartis.

BILL GARBARINI

CHIEF OPERATING OFFICER

BILL GARBARINI

CHIEF OPERATING OFFICER

Bill’s diversified pharmaceutical and healthcare background includes business development, M&A initiatives, and operations, product, and team building successes. Bill spent almost 15 years at Ferring Pharmaceuticals, where he was instrumental in building the company’s annual U.S. revenue from $20 million to $750 million, largely through the sales of fertility-related products. While at Ferring, Bill created and ran two new divisions, for which his responsibilities included all commercial operations.

In 2015, Reproductive Medicine Associates of New Jersey, the third largest IVF Clinic in the U.S., hired Bill as its Chief Development Officer – but quickly promoted him to Chief Operating Officer. As COO, Bill spearheaded the creation of the world’s largest assisted reproduction group via RMA’s merger with the Spanish fertility conglomerate IVI, valuing the combined firm at nearly $1 billion.

AMIT GUPTA

CHIEF INFORMATION OFFICER

AMIT GUPTA

CHIEF INFORMATION OFFICER

Amit has more than 20 years of experience as a leader, system architect and systems engineer on a wide variety of platforms. Amit’s core strength is building, scaling and monitoring extremely high volume, complex, mission-critical information systems using open source technologies, for high throughput and high availability software applications.

Amit has worked in senior technical roles with the TMRW Founders for more than 15 years as the VP, Infrastructure at Dstillery Inc, where he built and scaled infrastructure to handle over 160 billion events a day and over 2 million QPS using open source technologies. He was instrumental in helping the business grow from a $0 to an $80M run rate. In this role he also managed the integration of the infrastructure and technologies of an acquired mobile technology company.

A skilled negotiator and resource manager, Amit has routinely negotiated contracts and allocated services to save his companies millions while still ensuring impressive outcomes. Through technology, he focuses on strategic growth planning, optimizing performance, and streamlining operations. 

ANN WATSON

CHIEF MARKETING OFFICER

ANN WATSON

CHIEF MARKETING OFFICER

Ann has more than 20 years of experience leading brand marketing for luxury, lifestyle, fashion, and wellness companies.

Ann has served in senior marketing roles and as Chief Marketing Officer at a number of internationally known consumer brands, including the Ralph Lauren-owned Club Monaco, John Hardy, Sperry, and luxury department stores. She has a track record of executing high growth, brand-enhancing strategies targeting affluent and millennial audiences in the lifestyle, luxury, and wellness categories. She is an expert in leading cross-departmental teams, delivering strategic integrated marketing campaigns, and building comprehensive brand strategies. Her career highlights include roles as Senior Vice President and CMO at Sperry, and SVP of Global Marketing and Ecommerce at John Hardy, where — in addition to overseeing all Global Marketing — she helped lead a financial transition that secured a successful exit for the brand’s private equity investors while acquiring new funding. Ann also served as VP of Marketing and Communications at Club Monaco, leading the brand into the digital age and tripling revenue in less than three years. Additionally, she has held leadership roles at Neiman Marcus, Saks Fifth Avenue, and Henri Bendel.

JONATHAN AIN

OUTSIDE COUNSEL

JONATHAN AIN

OUTSIDE COUNSEL, PARTNER, KLEINBERG KAPLAN

Jonathan heads the Emerging Companies & Venture Capital practice at Kleinberg Kaplan. He specializes in the areas of mergers and acquisitions, public and private offerings (including PIPEs), strategic acquisition and disposition transactions, joint ventures and general corporate, cross-border transactions, and securities law and contract matters.

Jonathan regularly counsels enterprises across a wide breadth of industries, including software, technology, financial services, pharmaceuticals and healthcare, and is experienced in working with companies at all stages of the corporate growth cycle. He often serves as outside general counsel for his clients, with Jonathan and his group acting as a senior member of the client team and participating in board-level discussions.

Jonathan was recognized as a "Rising Star" by New York Super Lawyers in 2011 through 2013, and a "Super Lawyer” every year since 2014. He earned a J.D. from the University of Pennsylvania.

DAVID BAKER

MANAGING DIRECTOR, CLINICAL PARTNERSHIPs

DAVID BAKER

MANAGING DIRECTOR, CLINICAL PARTNERSHIPs

David has both built and led high performing sales teams in the women’s health and fertility market for almost twenty years. In 2004, David joined Ferring Pharmaceuticals, now a leader in fertility but then a small company with less than $20 million in revenue. Within a year of joining the firm, David was the highest performing member of the Ferring sales team. 

During David’s years at Ferring, the firm grew enormously with revenues approaching $750 million. As the company grew, David was tapped to be a regional sales manager, responsible for building a 150-person sales force for the Women’s Health division. Under his leadership, sales within this group approached $100 million. While at Ferring, David also participated in a number of multi-million dollar drug launches across a range of healthcare categories.

After leaving Ferring, David transitioned to the fertility specialty pharmacy industry with Integrity Specialty Pharmacy where he served as the Executive VP of Business Development. During his tenure, Integrity saw monthly sales grow from $300k to $3 million.

CHRISTINA BOU RAAD

DESIGN DIREctOR

CHRISTINA BOU RAAD

DESIGN DIRECTOR

Christina is a brand designer who enjoys pushing the boundaries of both creative and strategic thinking. She works alongside brands to help them vocalize and visualize their essence by building equity and sustainable relationships with their audience.

Before joining TMRW, Christina worked as Design Director for Union Design in New York, where she collaborated with a team of design and tech experts to develop advanced solutions for such clients as Brookfield, MoMA and CVS.

Born in Beirut, Christina is well traveled and speaks English, French and Arabic fluently, making her a skilled designer with a keen global perspective. Christina received her BS in Graphic Design at the Lebanese American University in Lebanon, followed by her Masters in Professional Studies in Branding at The School of Visual Arts in New York.

ALICIA BROUSSARD, Ph.D.

DIRECTOR, EMBRYOLOGY

ALICIA BROUSSARD

DIRECTOR OF EMBRYOLOGY

In addition to supporting research at TMRW, Alicia leads TMRW’s training function to introduce embryologists to the TMRW platform. Alicia is a clinical operations executive and innovator with a foundation in academic research and over 15 years of clinical research acumen.

Most recently a Clinical Research Manager at ReproSource, a reference laboratory for infertility diagnostics, she work with multiple IVF professionals on clinical studies aimed towards improving patient care. In the laboratories she has worked in, Alicia has successfully introduced and implemented new protocols and procedures in IVF labs, as well as developed, obtained funding for, and led Institutional Review Board-approved clinical research studies. This remit included the design, development, monitoring, and evaluation of study protocols in compliance with FDA and GCP standards and regulatory guidelines critical for obtaining scientifically sound and valid data.

Over he tenure as a full-time embryologist at Midwest Fertility Specialists and The Center for Reproductive Biology, she spearheaded clinical research, publishing numerous peer-reviewed studies in industry journals, such as the Journal of Fertility and Sterility and Theriogenology, and presenting results at industry conferences. Topics ranged from “High Sperm DNA Fragmentation on the Day of Oocyte Retrieval is Correlated with Lower Fertilization and Slower Development to the Blastocyst Stage for Trophectoderm Biopsy” to “Validation of Vitrification: Post-Warming in Vitro Maturation and Blastocyst Outgrowth.” Beyond reporting key findings, she collaborated with physicians, medical researchers, and scientific writing personnel to support the accurate interpretation and dissemination of the conclusions.

Alicia’s background enables her to forecast and understand the needs and challenges of the embryologists she trains to connect TMRW’s technology with current lab practices. It also facilitates her collaboration with TMRW’s engineers and designers to develop embryologist-friendly technologies.

Driven by her desire to advance IVF, Alicia remains an instructor at Eastern Virginia Medical School, where she earned her Ph.D. in Reproductive Clinical Sciences and where she mentors the next generation of embryologists. Since 2006, she has also served as a Technical Supervisor in Embryology and Andrology for the American Board of Bioanalysts. She is a member-at-large of the Society for Reproductive Biologists and Technologists as well as a member of the American Society for Reproductive Medicine, Society for the Study of Reproduction, and Society for Male Reproduction and Urology.

LAUREN CASAMASSIMA

Head of Coaching & People

LAUREN CASAMASSIMA

HEAD OF COACHING & PEOPLE

For the past 20 years, Lauren has provided personalized coaching, mentoring, and leadership training to businesses and leaders around the globe. During that time, Lauren has raised the performance level of creative entrepreneurs, senior executives and the teams and managers that they rely on.

Throughout her career, she has carefully curated programs for leading companies in the hospitality, retail, and technology sectors offering one-one coaching, team building, communication workshops, culture creation, management training and more. In these ongoing engagements, she often works directly with a company’s Board of Directors.

Prior to her starting her own consulting business, Lauren was the senior People & Culture executive at such bellwether firms as the The Standard Hotels and NeueHouse. She began working independently in order to provide a resource to the heads of ambitious, innovative companies seeking to address the promise of effective management in the area of people and culture.

Whether in the role of a business development strategist, a human behavior specialist, or a general motivator, Lauren believes everyone needs a supportive challenge to maximize their potential.

MICHAEL COLLINS, Ph.D.

MANAGING DIRECTOR, SCIENTIFIC AFFAIRS

MICHAEL COLLINS

MANAGING DIRECTOR, SCIENTIFIC AFFAIRS

Michael has 25 years of reproduction health experience spanning medical affairs, clinical development, drug discovery, scientific communication, regulatory affairs, and managed markets and business development. He has also played an important role in the expansion of the reproductive health business units at both Ferring Pharmaceuticals and Organon Inc.

While at Ferring, Michael held various positions including Director of Scientific Training before moving to Director of Strategic Accounts where he built and led a strategic account team in the successful execution of several high profile programs and projects.

A New Orleans native, Michael holds a Master of Science and a Doctor of Philosophy in Reproductive Physiology from Louisiana State University and has published work on many different levels within scientific literature. He is a member of ASRM, The Endocrine Society, and the Society for the Study of Reproduction where he was appointed to the Annual Meeting Industry Relations Committee in 2013.

RACHEL GREENBERG

MANAGING DIRECTOR, PROJECT MANAGEMENT

RACHEL GREENBERG

MANAGING DIRECTOR, PROJECT MANAGEMENT

Rachel recognized the transformative nature of the Internet early on. In the early 90s she began her career in the financial services industry at MBNA, working on what would become the multi-billion dollar affinity credit card industry.

Rachel later joined DASH.com, the pioneering consumer shopping app which was funded by AT&T Ventures and Omnicom and praised by TIME Magazine as “the Best of the Internet 1999”. While there, she was awarded the title of Vice President of Strategic Partnerships.

After DASH, Rachel worked as the senior operations executive in a number of Internet marketing firms. During this time, she had the opportunity to work with the future TMRW founders by helping their teams integrate technology into their businesses while maximizing efficiencies through improved process.

LEXI HENKEL

senior DIRECTOR, FINANCE & strategy

LEXI HENKEL

SENIOR DIRECTOR, FINANCE & STRATEGY

As Senior Director, Lexi is responsible for all financial aspects of TMRW’s strategy. She coordinates corporate finance and manages company policies regarding capital requirements, debt, taxation, equity and funding. 

Prior to joining TMRW, Lexi worked at Morgan Stanley in the Financial Sponsors Group, where she performed in-depth financial modeling and analysis to advise clients on potential leveraged buyouts, mergers, IPOs and recapitalizations. She worked on numerous transactions involving many of the largest and most sophisticated private equity firms in the industry.

Before working in the financial services industry, Lexi’s passion for science and medicine led her to roles at Mount Sinai Medical Center and Longitude Capital, a private investment firm with $1.2 billion AUM focused on venture growth investments in drug development and medical technology. At Longitude, Lexi conducted company and industry research and evaluated clinical-stage specialty pharmaceutical companies.

Lexi graduated summa cum laude and Phi Beta Kappa from Yale University with dual degrees in Economics and Spanish.

APRIL KOMPLIN

QUALITY AND REGULATORY AFFAIRS MANAGER

APRIL KOMPLIN

QUALITY AND REGULATORY AFFAIRS MANAGER

April’s extensive and diversified experience in the science industry spans clinical laboratories, medical device manufacturing, custom biological product manufacturing, and laboratory animal science.

She comes to TMRW from Envigo RMS, Inc. where she was the Compliance Manager, supporting all Envigo sites across North America. While there, she managed compliance and developed quality systems to cover an array of products and services including monoclonal antibodies, live animal models, laboratory animal diet, and transportation.

April has over 8 years of experience in Quality Assurance and also has vast experience with an array of regulatory and accreditation agencies including FDA, USDA, ISO, and AAALAC.

April holds a Master’s Degree in Clinical Microbiology and has taught college-level courses in Microbiology, Urinalysis, Hematology, Immunology, and Public Health.

KAJ RYDMAN

MANAGING DIRECTOR, EUROPE

KAJ RYDMAN

MANAGING DIRECTOR, EUROPE

At TMRW, Kaj will be responsible for launching and growing TMRW’s European operations as Managing Director.

Over his 25+ year career in the fertility space, Kaj has led finance and operations at the largest reproductive tissue bank in the world, helping it to branch into critical and profitable new markets. But his biggest calling has been to drive significant innovations in safety and oversight into the care of reproductive tissues.

Kaj spent much of his career at California Cryobank, the largest reproductive tissue bank in the world, in roles spanning from CFO, President of the Stem Cell Division, and VP of Operations. He led a number of expansions and innovations, eventually working with hundreds of IVF clinics and running a reproductive bio-repository with over 700,000 specimens.

Kaj helped launch California Cryobank’s egg freezing division. He also relaunched and expanded its fledgling cord blood business by increasing marketing and creating strategic partnerships with doctors. During his time as a key executive at California Cryobank, the company became the largest stem cell bank and the largest donor egg bank in the world.

When auditing IVF clinics for partnerships with California Cryobank’s egg-freezing business, Kaj noticed many clinics’ cryo-storage operations were substandard when compared to their clinical work. To address this issue, he left California Cryobank to found IVFCryo, which consults with leading clinics across the country, to help them to establish biorepository-grade cryo-management.

At IVFCryo, Kaj and his team assessed clinics’ cryo-management and made recommendations to bridge the gaps, develop standard operating procedures, and trained staff to perform the processes properly, helping them redesign clinics where necessary. With his arrival at TMRW, Kaj will remain Non-Executive Chairman of IVFCryo.

APRIL KOMPLIN

QUALITY AND REGULATORY AFFAIRS MANAGER

April’s extensive and diversified experience in the science industry spans clinical laboratories, medical device manufacturing, custom biological product manufacturing, and laboratory animal science.

She comes to TMRW from Envigo RMS, Inc. where she was the Compliance Manager, supporting all Envigo sites across North America. While there, she managed compliance and developed quality systems to cover an array of products and services including monoclonal antibodies, live animal models, laboratory animal diet, and transportation.

April has over 8 years of experience in Quality Assurance and also has vast experience with an array of regulatory and accreditation agencies including FDA, USDA, ISO, and AAALAC.

April holds a Master’s Degree in Clinical Microbiology and has taught college-level courses in Microbiology, Urinalysis, Hematology, Immunology, and Public Health.

ROB DESANNO

MANAGING DIRECTOR, SYSTEMS ENGINEERING

ROB DESANNO

MANAGING DIRECTOR OF SYSTEMS ENGINEERING

As Managing Director of Systems Engineering, Rob is responsible for maintaining the “self-healing” backend and keeping a watchful eye on all services that power the TMRW infrastructure.

Prior to joining TMRW, he worked as a Senior Systems Administrator for 5 years at Dstillery, a midtown Manhattan ad-tech company. There he was responsible for maintaining 2,600 physical servers and over 65,000 individual services which contribute to an astounding 1.8 million queries per second.

Rob has also worked exclusively in Information Technology for major corporations such as Novartis, St. Barnabas Health Care, Calvin Klein, Party City, and Prudential.

CIARA GRENNEN

OPERATION MANAGER

CIARA GRENNEN

OPERATIONS, MANAGER

While in college, Ciara became fascinated with Procurement & Supply Chain Management. Since then, she has demonstrated a proven track record of accomplishment in the medical device industry. During her career, Ciara has received international recognition for establishing premier relationships with global supply chain teams.

Before joining TMRW, Ciara worked in Ireland then Amsterdam, where she held the position of Senior Purchasing and Planning Analyst at the European headquarters of Stryker, a leading medical device company. While there, Ciara’s achievements ranged from being a key contributor in the successful opening of the European Buying Center to drastically reducing lead times and costs.

Ciara received her BA from St. Joseph’s College in Patchogue, NY and her Master of Science (MS) Supply Chain Management from the UCD Michael Smurfit Graduate Business School in Dublin, Ireland.

CYNTHIA HUDSON

EXECUTIVE DIRECTOR, EMBRYOLOGY

CYNTHIA HUDSON

EXECUTIVE DIRECTOR, EMBRYOLOGY

Cynthia is the executive in charge of TMRW’s Embryology Team. An embryologist and medical technologist with over 20 years of experience in reproductive technology, Cynthia possesses a holistic industry perspective born from her diverse and comprehensive background: She has worked in a number of the nation’s foremost IVF practices and designed multiple IVF laboratories, in addition to founding and operating innovative reproductive medicine centers.

As Founder and CEO of Manhattan Fertility Services, a full-service fertility center with in-house IVF lab, Cynthia built and operated the practice while developing a pioneering patient experience and new, viable revenue streams. Her creation of a reference andrology lab, management corporation, and associated medical practice played a critical role in the center’s growth and eventual sale.

She applied this same holistic expertise as co-Founder of Kindbody — a revolutionary reproductive firm that combines best-in-class technology, clinical excellence, and accessible pricing to connect the full patient experience on one intuitive platform. And as Founder and CEO of Cellavita, an Assisted Reproductive Technology consulting service established in 2004, Cynthia offered a variety of advisory and laboratory services to a wide range of corporate clients and domestic and international clinical IVF programs.

Cynthia is a member of multiple medical organizations, including the American Board of Bioanalysis, American Society for Reproductive Medicine, and American College of Embryology. She is an active researcher who co-authored a seminal study on improving IVF success rates using frozen embryos, and she has made dozens of published contributions to leading scientific journals, such as Fertility & Sterility, Human Reproduction, and Science. Her work has also been featured in presentations at the American Society for Reproductive Medicine and European Society for Human Reproduction and Embryology.

STANLEY KUBASEK

Managing Director, Software Engineering

STANLEY KUBASEK

MANAGING DIRECTOR, SOFTWARE ENGINEERING

As a senior Java Software Engineer, Stanley has over 15 years of Java experience in software development and design, the last 6 of them as a team leader. His interest in software architecture, design patterns, and agile and iterative processes is only eclipsed by his interest in growing and promoting talented developers.

Stanley’s expertise in languages ranges from Java to HTML. His record of leading successful projects runs the gamut from frameworks to micro-services/big data.

As a senior Software Engineer at marketech pioneer Dstillery, Stanley managed a team of 4 developers building a realtime bidding platform which routinely handled 100B+ daily events. Under his lead, numerous improvements to the development process were made to make effective changes that made the system faster, more efficient and less error prone.

Prior to his role at Dstillery, Stanley was a Senior Software Engineer at NBC Universal.

Stanley received his M.S. in Computer Science at New Jersey Institute of Technology.

TIM SHARP

MANAGING DIRECTOR, OPERATIONS

TIM SHARP

MANAGING DIRECTOR, OPERATIONS

Tim is one of the world’s leading experts on biorepository operations. 

For many years he managed the largest human tissue repository in the U.S. for the National Institutes of Health’s Central Repository Service. His work was critical in supporting research for cancer treatment and prevention through tissue, blood product, and biopsy collection and distribution.

Immediately prior to joining TMRW, Tim served as the Global Biorepository Director for ICON plc, where he led sample management and storage, cold chain logistics, repository services, and strategic sponsor partnerships across three continents for clients such as Kite, June, and Gilead. Prior to ICON, Tim served as the principal technical expert for global biorepository/biospecimen operations, cryobiology, and cold chain operations at the American Type Culture Collection. He headed the global inventory operations department for multiple ATCC operations around the world, totaling 18 million specimens. 

Tim’s extensive leadership experience in biorepository operations has made him a key player in developing industry processes and controls. He currently serves on the Standards Coordinating Body drafting the ISO TC276 Cell and Regenerative Medicine standards for cell therapy transport and biobanking.

Tim has published extensively in professional journals related to cryopreservation. In addition, he is the primary author of several U.S. patents, both granted and pending.

Prior to beginning his career in cryostorage, Tim served in the U.S. Army in sensitive logistics roles in Afghanistan and Uzbekistan.

LAURA ROCCHI

EXECUTIVE ASSISTANT

Laura grew up in the south of France in Montpellier, perhaps the oldest university town in the world with some of the institutions boasting roots in the 10th century. She graduated from the Tunon hospitality school before returning to Montpellier to manage her family’s long established restaurants in that city. A passion for adventure and travel led her to spend two years working in London before coming to New York to study at the Fashion Institute of Technology. Post FIT she joined the atelier of leading fashion stylist Juliana Gimenez organizing that firm's work with leading U.S. fashion brands and magazines.

KATHRYN GO, Ph.D., HCLD

MANAGING DIRECTOR, EMBRYOLOGY

KATHRYN GO, Ph.D., HCLD

MANAGING DIRECTOR, EMBRYOLOGY

Kathryn has been a laboratory director and practicing embryologist for more than 30 years. After 21 years as Laboratory Director at Pennsylvania Reproductive Associates, she spent 11 years as Scientific and Laboratory Director at IVF New England. More recently, she has served as the Director, Embryology Laboratory, Boston IVF - The Maine Center and Director, Clinical Laboratory, ReproSource Fertility Diagnostics.

Kathryn has been on the faculties of the medical schools of the University of Pennsylvania, Thomas Jefferson Medical University and the University of Massachusetts and has taught at the Medical College of Pennsylvania and the Experimental College of Tufts University. Kathryn has served on the executive council of the Society for Assisted Reproductive Technology, been a consultant to the FDA, and has served as chair of the Reproductive Biology Professional group of the American Society for Reproductive Medicine. She is also past President of the New England Fertility Society (NEFS) and currently serves as its Member-at-Large for Industry. 

Kathryn holds a Ph.D. in molecular biology from the University of Pennsylvania.

BENJAMIN HARLOW

PRODUCT DESIGN DIRECTOR

BENJAMIN HARLOW

PRODUCT DESIGN DIRECTOR

Benjamin has more than 10 years of experience in designing and building products along every stage of the process. A proven problem solver, he is committed to practical design solutions that are user-centric in achieving their goal.

He began his career at various technology startups in New York City, working on everything from iPhone and Android apps, websites, and data visualizations. Most recently, he was a Senior UX Architect at the MarTech pioneer Distillery where he was responsible for the UI/UX efforts, the Front-End Team, maintaining existing SaaS products, and developing new products.

Benjamin graduated from The Australian National University with a BA in Digital Arts in his hometown of Canberra, Australia. He came to New York City soon after and has called it home for the last 12 years.

ORIANA JACKSON

OFFICE MANAGER

ORIANA JACKSON

OFFICE MANAGER

Oriana has over 12 years of experience successfully supporting internal and client-facing business operations within early-stage globally-focused technology startups.

Prior to joining TMRW, Oriana was the Sales Operations Manager of Balabit, (a European-based B2B international cybersecurity firm) where she managed a 26-person U.S. & Canada team via streamlining all training, professional development, and logistical needs for the company’s highest performing region.

In her last year at Balabit, she sold and processed $11 Million of B2B cybersecurity hardware and software in advance of the company’s acquisition by One Identity.

A graduate of Fordham University with a BA in Sociology, Oriana has extensive knowledge of the global landscape, having worked across multiple industries within Germany, Hungary, India and Sweden.

LAURA ROCCHI

EXECUTIVE ASSISTANT

BENJAMIN HARLOW

PRODUCT DESIGN DIRECTOR

BLaura grew up in the south of France in Montpellier, perhaps the oldest university town in the world with some of the institutions boasting roots in the 10th century. She graduated from the Tunon hospitality school before returning to Montpellier to manage her family’s long established restaurants in that city. A passion for adventure and travel led her to spend two years working in London before coming to New York to study at the Fashion Institute of Technology. Post FIT she joined the atelier of leading fashion stylist Juliana Gimenez organizing that firm's work with leading U.S. fashion brands and magazines.

 

INDEPENDENT DIRECTORS

TARA COMONTE

TARA COMONTE

Currently CFO at Shake Shack (NYSE: SHAK), the high growth, fast casual restaurant chain originally founded by Danny Meyer and Union Square Hospitality Group, Tara is responsible for leading all aspects of finance and technology across the company, as well as partnering with the CEO to provide overall strategic direction for the broader business. At ~200 operations globally today, the company is on a path to continue to deliver significant growth both domestically and internationally over the coming years.

Prior to joining Shake Shack, Tara was EVP and Chief Financial & Business Affairs Officer at Getty Images, the leading global digital marketplace for images, video & music content. At this ~$1 billion revenue, PE-backed company, she managed all aspects of the global finance and the technology applications & development functions. Earlier in her career, Tara served as Chief Financial Officer at McCann Worldgroup, the world’s largest advertising firm and part of Interpublic Group. Previously, she was a founding executive of Mediabrands, IPG’s award-winning media group, managing more than $30 billion of billings globally, where she served as Global CFO and COO. She began her career in public accounting with Ernst & Young in the United Kingdom.

Tara believes in promoting a culture of empowerment and partnership, and this approach has been recognized throughout her career. In 2012, Tara was named a World Economic Forum Young Global Leader. She was the first CFO inducted into the American Advertising Federation Hall of Achievement, received the Industry Innovator & Quantum Leap Award from Advertising Women of New York, and is a Crain’s New York Business “40 under 40” awardee.

A proud native of Scotland, Tara lives in Brooklyn, New York with her partner Chris, and three children, Lachlan, Xander and Skye.

EMILY DRABANT CONLEY, PH.D.

EMILY DRABANT CONLEY, PH.D.

Emily has served as Vice President of Business Development for 23andMe since 2010, a position in which she has demonstrated a passion for accelerating clinical progress and improving patient care by disrupting healthcare inefficiencies.

At 23andMe Emily is responsible for setting company strategy, including leveraging and monetizing the firm's innovative database. She oversees business and corporate development as well as alliance management. She has a proven track record of forging groundbreaking partnerships with leaders in pharma, biotech, digital health, big data, retailers, CPG, traditional healthcare, and academia.

Deeply involved in capital strategy, Emily was instrumental in developing 23andMe’s partnership with GlaxoSmithKline which resulted in a $300 million equity investment from GSK.

Prior to 23andMe, Emily spent 10 years conducting research that combined genetics and neuroimaging to understand neuropsychiatric disease. She was a Research Fellow at the National Institute of Mental Health and is a co-author on more than 30 academic publications. She formerly served on the Advisory Board of Lesbians Who Tech, an organization dedicated to increasing diversity representation in the technology industry. She also previously served on the board of the UCSF Alliance Health Project, a clinic which provides services to the LGBT and HIV-affected communities in San Francisco.

Emily received her Ph.D. in Neuroscience from Stanford University School of Medicine, where she held fellowships from the National Science Foundation and Department of Defense. She graduated summa cum laude from Vanderbilt University with a B.A. in Psychology and Business.

ROBBIE MYERS

ROBBIE MYERS

Robbie Myers, recently appointed as Editor-in-Chief of Shondaland.com, has been leading top media brands for over 25 years.

Robbie most recently served for 18 years as the Editor-in-Chief of ELLE, the number one fashion magazine in the world. Under her leadership, the brand experienced unprecedented success—including a 53% increase in readership—while maintaining its reputation for covering fashion, luxury, beauty, culture, and social and political issues from an elevated perspective, informed by Robbie’s commitment to journalistic integrity, and bold visual storytelling, eventually reaching more than 28 million readers, users, and fans across all mediums, including print, digital, mobile, and social. During her tenure, ELLE enjoyed 16 straight quarters of revenue growth—twice—and with the September 2015 issue, published the largest issue in parent company Hearst’s 128-year-history. Robbie also made sure ELLE was the first fashion magazine brand to: capture an immersive VR fashion experience; partner with an unscripted TV show, Project Runway; feature content on Google Glass; debut a weekly interactive tablet edition; and introduce a social shopping platform.

Robbie is a former vice president of the American Society of Magazine Editors and has been recognized for her accomplishments throughout the media and fashion industries. Forbes included her on its list of Most Powerful U.S. Fashion Magazine Editors; The Business of Fashion featured her as one of the most influential people shaping the global fashion industry; and Gotham dubbed her a Media Power Player. She has received six ASME nominations over her career, including General Excellence, she’s been honored by New York Women in Communications with a Matrix Awards and received the Marylou Luther Award for Fashion Journalism.

 

SCIENTIFIC ADVISORY BOARD

ANDREW BROOKS, Ph.D.

CHAIRMAN OF THE SCIENTIFIC ADVISORY BOARD

ANDREW BROOKS, Ph.D.

CHAIRMAN OF THE SCIENTIFIC ADVISORY BOARD

Andrew is the Chief Operating Officer of RUCDR Infinite Biologics (RUCDR) at Rutgers University, the world’s largest academic biorepository managing critical biological resources for clients such as The National Institute of Health, leading academic researchers, and major pharmaceutical and biotechnology companies. 

Additionally, Andrew is the Chief Scientist for TMRW’s infrastructure partner, Brooks Life Sciences, a division of the $2 billion (NASDAQ) Brooks Corporation. 

Andrew is also a Professor of Medicine and Genetics at Rutgers University. He is trained in molecular neuroscience and gene therapy and is widely recognized as a thought leader in the field of personalized medicine. 

Andrew has deep experience in advising leading US, global institutions, and governments on health policy, including serving on the boards and scientific leadership of several global biorepository and precision medicine programs in Europe, Qatar, and Australia.

DAVID SABLE, MD

DAVID SABLE, MD

David Sable directs healthcare and life science investing for the Special Situations Funds and is portfolio manager of the Special Situations Life Sciences Fund.

After graduating from the Wharton School and the University of Pennsylvania School of Medicine, David trained in obstetrics and gynecology at New York Hospital - Cornell Medical Center, and in reproductive endocrinology at the Brigham and Women's Hospital. He co-founded and served as director of the Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center in New Jersey, was founder and CEO of Assisted Reproductive Medical Technologies, which was acquired by Saint Barnabas in 1999, and co-founder of Reprogenetics, acquired by Cooper Surgical in 2015. After leaving clinical medicine, Dr. Sable managed a proprietary healthcare portfolio at Deutsche Bank before joining the Special Situations Funds. 

David is an adjunct in the department of biology at Columbia University, and teaches “Entrepreneurship in Biotechnology” at Columbia’s Graduate School of Arts and Sciences. He has lectured on healthcare investing, policy, and biotechnology business development at the Wharton School, NYU, Rockefeller University and Rutgers; has delivered keynote addresses to the American Fertility Society, the Texas Fertility Society and the Mexican Fertility Society; and appeared on the CBS Morning News, ABC World News Tonight, NY1 News and PBS’ Nova to discuss innovation in reproductive medicine. He has served as a board member for Genenews Inc, Hamilton Thorne Ltd, and for the nonprofit advocacy organization RESOLVE, and on the medical and scientific advisory boards of Ovascience and Progeny. In addition to his academic publications, he is a regular contributor to Forbes, covering the reproductive medicine industry. 

MINA ALIKANI, Ph.D., HCLD

MINA ALIKANI, Ph.D., HCLD

Mina is a renowned international expert in assisted reproduction. During her 35 years in the field, she has worked extensively on improving IVF laboratory performance and outcomes. Mina has lectured worldwide on ART topics, and she has authored and co-authored more than 70 articles and book chapters on laboratory aspects of assisted reproduction. 

  Early in her career, Mina worked with Dr. Jacques Cohen to establish the laboratories of The Center for Reproductive Medicine at Cornell University Medical Center (now Weill Cornell Medicine) in New York, and the Institute for Reproductive Medicine and Science of Saint Barnabas Medical Center in New Jersey as two of the leading reproductive medicine laboratories in the world.

More recently, Mina has served as a laboratory director, clinical consultant, and research scientist for ART labs in the U.S. and abroad. During her time as Director of Laboratories at the Center for Human Reproduction of North Shore University Hospital (now Northwell Health) in Long Island, she led the laboratory team in successfully implementing the center’s first blastocyst biopsy program. 

Mina is an editor of the journal Reproductive Biomedicine Online and an Editorial Board member of the journal Fertility and Sterility. She is also an Executive Board member of Alpha Scientists in Reproductive Medicine. She holds a Ph.D. from Monash University in Australia, and she is certified as a High-Complexity Clinical Laboratory Director and Clinical Consultant.

PAUL WEATHERSBEE, Ph.D.

PAUL WEATHERSBEE, Ph.D.

Paul brings 39 years of innovative knowledge and expertise to the field of human reproductive cryobiology. Throughout his career, he has consistently fortified the bridge between clinical medicine and laboratory science.

Paul earned his PhD at the University of Illinois and completed his post-doctoral fellowship at the University of Washington. Immediately thereafter, Paul joined the Department of Obstetrics and Gynecology at the University of California at Irvine College of Medicine as an Assistant Professor where he directed the reproductive endocrine laboratory for six years.

Paul went on to hold numerous positions at Irvine Scientific, bringing the first quality-controlled, commercially prepared culture medium and culture supplements designed for fertility to the marketplace.

Paul’s commitment to innovation and advances in care for infertility patients is reflected in the launch of 9 fertility medications during his tenures in the pharmaceutical industry. In 1994, he joined Organon, Inc. as the Assistant Director of Medical Affairs, and in 1998, became the Director of Medical Affairs in Reproductive Health at Serono Laboratories, Inc. As the Director of Medical Affairs at Ferring Pharmaceuticals, Inc. where he joined in 2003, Paul led the field medical efforts in Reproductive Health.

In 2006, the American Fertility Association recognized Paul and his contributions with a Family Building Award.

JACQUES COHEN, Ph.D.

JACQUES COHEN, Ph.D.

Jacques is the pioneering Dutch academic, embryologist and entrepreneur who has been associated with many of the critical innovations in Assisted Reproductive Technology (ART) over the past 40 years.

After receiving his B.Sc. in Biochemistry from the State University of Leiden, Jacques went on to receive an M.Sc. in Reproductive Physiology from Leiden University. In 1981, he was awarded his Ph.D. in Medicine from Erasmus University.

Immediately after receiving his doctorate, Jacques joined the groundbreaking Bourn Hall Clinic Cambridge as an Embryologist, working with Patrick Steptoe and Robert G. Edwards on techniques geared towards improving human conception through in vitro fertilization (IVF). Edwards was the recipient of the Nobel Prize for Medicine and Physiology in 2010 in recognition of his pioneering work including the birth of Louise Brown, the first IVF child. It was in Cambridge that Jacques was the first scientist to successfully freeze and thaw a human blastocyst for use in IVF, an achievement that provided the foundational platform for many of the innovations that were to come in ART during the next 30 years. Evidence of his many contributions to the field, Jacques is the author of 12 patents relating to ART.

A serial entrepreneur, Jacques is the co-founder of Althea Science, which develops software solutions for laboratories and clinics. He was co-founder of Reprogenetics, a genetic screening service used in fertility clinics, which was acquired by Cooper Genomics in 2015. In addition, Jacques co-founded Life-Global/IVF-Online, a company also acquired by Cooper Surgical in 2018. Jacques was the founder of Alpha – Scientists in Reproductive Medicine, a leading global professional group for scientists working in ART.

A widely published author, Jacques has written more than 300 articles for peer-reviewed scientific publications and authored several foundational textbooks concerning issues in ART. He is also Emeritus Chief Editor of Reproductive Biomedicine Online.

Jacques is the founder and Director of the ART Institute of Washington, which was selected by the National Institutes of Health and Walter Reed National Military Medical Center to develop and run their joint IVF program at Walter Reed.

 

ADVISORY BOARD

ARTHUR CERIA

ARTHUR CERIA

Currently the Vice President of Strategic Innovation at Philip Morris International, Arthur has a long history as a pioneer in digital marketing and marketing innovation.

Part of the early team at agency.com, Arthur went on to run the San Francisco office of Ogilvy & Mather’s OgilvyOne where he led digital efforts for such brands as Yahoo! and Cisco. Arthur left Ogilvy and co-founded the award-winning digital agency CreativeFeed, which made the list of Fortune’s 100 fastest growing U.S. agencies.

Arthur’s work has garnered awards including the One Show, @d:Tech Award for Best Consumer Site, Adweek’s Best Online Campaign of the Year, and the MSN Creative Award for Best Rich Media.  

Known for his humor, Arthur also launched the popular “Squeeze The Banker” stress dolls as an antidote to the 2008 financial crisis. Born and raised in Paris, Arthur received his MFA from Yale University and Ecole National Superieure des Arts Decoratifs.

JAMIE METZL

JAMIE METZL

Jamie Metzl is a technology futurist and geopolitical expert, entrepreneur, media commentator, and Senior Fellow of the Atlantic Council. He previously served in the U.S. National Security Council, State Department, Senate Foreign Relations Committee and as a Human Rights Officer for the United Nations in Cambodia. Jamie is a former Partner of a New York-based global investment firm, serves on the Advisory Council to Walmart’s Future of Retail Policy Lab, is a faculty member for Singularity University’s Exponential Medicine conference, was Chief Strategy Officer for a biotechnology company, and ran unsuccessfully for the U.S. House of Representatives from Missouri’s Fifth Congressional District in Kansas City in 2004.

Jamie appears regularly on national and international media discussing Asian economic and political issues and his syndicated columns and other writing on Asian affairs, genetics, virtual reality, and other topics are featured regularly in publications around the world. He is the author of a history of the Cambodian genocide, the historical novel The Depths of the Sea, and the genetics thrillers Genesis Code and Eternal Sonata. His non-fiction book Hacking Darwin: Genetic Engineering and the Future of Humanity will be published by Sourcebooks in Spring 2019.

Jamie is a member of the Council on Foreign Relations, a former White House Fellow and Aspen Institute Crown Fellow. Jamie holds a Ph.D. in Asian history from Oxford, a JD from Harvard Law School, and is a magna cum laude, Phi Beta Kappa graduate of Brown University.

AGNES FISCHER

AGNES FISCHER

Agnes is an advertising executive with an impressive mix of experiences, ranging from running accounts at global networks, digital agencies and creative hot shops. She has been helping her clients navigate marketing, creative and the ever changing media landscapes for 15+ years, while ensuring that the agencies she worked for had the right talent, operations, and strategies to deliver for their clients. From Publicis, where she worked on P&G, to LBi, where she ran J&J Beauty, to Anomaly, her experience combines leading big brands with rigorous strategic thinking and start-up brands with a test and learn approach. She has been at one of the most awarded agencies in the world, Droga5, since 2015. There, she has built the JPMorgan Chase Consumer Bank business and also oversees clients like The New York Times and Nordstrom, all while running the Account Management department at the agency.

Alongside her professional pursuits, Agnes has also been an advocate for fertility awareness. After spending most of her twenties and early thirties avoiding pregnancy and assuming there was plenty of time for marriage and kids, she had a rude awakening in her mid thirties, when she and her then husband tried to have children. It was then that she realized that fertility is fleeting, and that we should be having more open and realistic conversations about it. This realization led her to chronicle her experience with freezing her eggs on her blog frozenplease.com, which caught the attention of a publisher who approached her about writing a book on the subject. In 2016, Agnes's book Eggs Unscrambled: Egg Freezing, Fertility, and the Truth About Your Reproductive Years, was published by Regan Arts.

ELLEN LUBMAN

ELLEN LUBMAN

Ellen is Chief Business Officer of Impel Neuropharma, a private neuroscience therapeutics company, where she leads corporate development activities and strategy. Prior to joining Impel, she served as the Vice President of External Science & Innovation at Allergan, where she was responsible for strategic expansion of the company’s pipeline in a variety of disease areas, including women’s health.

Ellen has 20 years of biopharmaceutical corporate development and Wall Street industry experience, including roles at Kadmon Pharmaceuticals, Bristol-Myers Squibb, Celtic Pharma Management, L.P., and Robertson Stephens.

She is a member of the Board of Directors of Dauntless Pharmaceuticals and GeneCentric Therapeutics.

STANLEY KUBASEK

MANAGING DIRECTOR, SOFTWARE ENGINEERING

As a senior Java Software Engineer, Stanley has over 15 years of Java experience in software development and design, the last 6 of them as a team leader. His interest in software architecture, design patterns, and agile and iterative processes is only eclipsed by his interest in growing and promoting talented developers.   Stanley’s expertise in languages ranges from Java to HTML. His record of leading successful projects runs the gamut from frameworks to micro-services/big data.   As a senior Software Engineer at marketech pioneer Dstillery, Stanley managed a team of 4 developers building realtime bidding platform which routinely handled 100B+ daily events. Under his lead, numerous improvements to the dev process were made to make effect changes that made the system faster, more efficient and less error prone.    Prior to his role at Dstillery, Stanley was a Senior Software Engineer at NBC Universal.   Stanley received his M.S. in Computer Science at New Jersey Institute of Technology.